CrossBridge Bio

Houston, United States

CrossBridge Bio operates as a biotechnology company.

$10.0M raised

Nov 2024

Seed

Biotechnology Therapeutics

Top Investors

Alexandria Venture InvestmentsPortal InnovationsTMC Venture FundCE-VenturesLinden Lake Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CrossBridge Bio

How much funding has CrossBridge Bio raised?

CrossBridge Bio has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in November 2024.

Who are CrossBridge Bio's investors?

CrossBridge Bio's investors include Alexandria Venture Investments, Portal Innovations, TMC Venture Fund, CE-Ventures, Linden Lake Ventures.

Where is CrossBridge Bio headquartered?

CrossBridge Bio is headquartered in Houston, United States.

What does CrossBridge Bio do?

CrossBridge Bio operates as a biotechnology company.

What stage is CrossBridge Bio at?

CrossBridge Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 4, 2024.

MLA

"CrossBridge Bio — Funding & Investors." VCBacked, November 4, 2024, https://www.vcbacked.co/company/crossbridge-bio. Accessed June 17, 2026.

APA

VCBacked. (2024). CrossBridge Bio — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/crossbridge-bio

Wikipedia (cite web)

{{cite web |title=CrossBridge Bio — Funding & Investors |url=https://www.vcbacked.co/company/crossbridge-bio |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 4, 2024.

Similar Companies in Biotechnology